- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Amarantus Bioscience Holdings Inc+ Add to Watchlist
AMBS:US0.0700 USD 0.0055 7.28%
As of 20:10:00 ET on 04/16/2014.
Company Profile for Amarantus Bioscience Holdings Inc (AMBS)
Amarantus Bioscience Holdings, Inc. is a biotechnology holding company. The Company, through its subsidiaries, certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinson's disease, traumatic brain Injury, Ischemic heart disease and other human diseases.
Amarantus Bioscience Holdings Inc
Key Executives for Amarantus Bioscience Holdings Inc (AMBS)
|Martin D ClearyChairman||Gerald E CommissiongPresident/CEO/COO|
|Marc E FaerberCFO/Controller||John W CommissiongChief Scientific Ofcr/Co-Founder|
|Russell MillerDirector:Investor Relations|